Investing

First Look Analysts Research Calls for Tuesday, January 31

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> FibroGen (FGEN) upgraded to Outperform from Mkt Perform at William Blair

> Inter & Co (INTR) upgraded to Buy from Neutral at Goldman; tgt lowered to $4.20

> LyondellBasell (LYB) upgraded to Overweight from Neutral at Atlantic Equities; tgt $110

> New Fortress Energy (NFE) upgraded to Buy from Neutral at BTIG Research; tgt $50

> Societe Television Francaise 1 (TVFCF) upgraded to Equal Weight from Underweight at Barclays

> WPP plc (WPP) upgraded to Overweight from Equal Weight at Barclays

Downgrades:

> Bank of America (BAC) downgraded to Neutral from Overweight at Atlantic Equities; tgt $40

> Eastern Bankshares (EBC) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $15

> Invitae (NVTA) downgraded to Sell from Neutral at Goldman; tgt $2

> iStar (STAR) downgraded to Mkt Perform from Outperform at Raymond James

> Nu Skin (NUS) downgraded to Hold from Buy at Jefferies; tgt lowered to $39

> Q2 Holdings (QTWO) downgraded to Neutral from Outperform at Robert W. Baird; tgt $32

> RELX (RELX) downgraded to Equal Weight from Overweight at Barclays

> Ubisoft (UBSFY) downgraded to Underperform from Buy at Jefferies

Others:

> Incyte (INCY) initiated with an Overweight at Piper Sandler; tgt $100

> Kura Oncology (KURA) initiated with a Buy at Stifel; tgt $25

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.